YOLFTbeta
Seouleaguer Co. Ltd

Seouleaguer Co. Ltd

043710 · KQ · Consumer Non-Cyclicals / Food & Drug Retailing

3,160.00KRW+75.00 (+2.43%)

Price History

Full chart

Market Stats

Previous Close3,085.00
Open3,300.00
Day Range3,040.00 – 3,300.00
52-Week Range2,555.00 – 5,630.00
Volume11.12K
Market Cap52.63B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.18
50-Day Avg3,181.90
200-Day Avg3,901.63

About

Seouleaguer Co., Ltd., a medical beauty care platform company, provides hospital management support services in South Korea. The company was formerly known as Rocketmobile Co., Ltd. and changed its name to Seouleaguer Co., Ltd. in July 2016. Seouleaguer Co., Ltd. was founded in 1991 and is headquartered in Seoul, South Korea.

Company Details

  • SectorConsumer Non-Cyclicals
  • IndustryFood & Drug Retailing
  • CEOPaek-Chol Kim
  • Employees14
  • Headquarters10, Nonhyeon-ro 163-gil, Seoul, South Korea, Korea
  • Websitehttps://www.seouleaguer.net

Leadership

  • Paek-Chol KimChief Exec. Officer · b. 1965

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue715.07M18.48B14.28B17.51B78.37B43.69B14.87B10.11B22.56B19.34B35.67B
Growth (%)-+2484.96%-22.72%+22.59%+347.54%-44.26%-65.95%-32.05%+123.21%-14.27%+84.43%
Cost of Revenue1.47B17.61B11.97B14.16B58.94B28.61B14.78B9.13B21.65B16.81B36.21B
Gross Profit-753.93M871.14M2.31B3.35B19.42B15.08B89.28M978.72M911.05M2.53B-542.72M
Gross Margin-105.43%4.71%16.19%19.14%24.79%34.51%0.60%9.68%4.04%13.08%-1.52%
Operating Expense1.76B1.41B1.46B7.01B29.50B46.67B817.82M7.37B14.11B2.76B7.79B
Operating Income-2.52B-535.30M848.58M-3.66B-10.08B-31.59B-728.55M-6.39B-13.20B-232.08M-8.33B
Operating Margin-352.23%-2.90%5.94%-20.90%-12.86%-72.32%-4.90%-63.19%-58.49%-1.20%-23.35%
EBITDA--------5.51B-2.24B4.83B-7.82B
EBITDA Margin--------54.53%-9.92%24.95%-21.93%
Net Income-5.98B-2.47B-1.41B-3.83B-7.11B-25.03B-5.79B-6.39B-3.30B5.38B-8.74B
Net Income Margin-836.40%-13.38%-9.84%-21.88%-9.08%-57.30%-38.90%-63.18%-14.61%27.82%-24.51%
R&D683.78M---------193.84M
R&D as % of Total Revenue95.62%---------0.54%
Interest Expense000003.69B1.69B486.63M600.56M556.93M2.67B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%8.45%11.37%4.81%2.66%2.88%7.50%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.41B43.26B38.21B62.81B119.15B99.43B38.47B38.16B37.39B50.23B226.45B
Total Liabilities3.20B3.74B1.58B14.96B68.47B71.00B12.54B8.06B10.48B11.10B187.18B
Total Equity14.20B39.52B36.63B47.85B50.67B28.43B25.93B30.10B26.91B39.13B35.74B
Cash6.91B12.32B6.99B7.52B12.18B8.44B292.47M437.37M2.49B13.28M6.93B
Total Debt----19.81B30.20B-----
Net Debt----21.72B33.56B----139.57B

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.83B-8.28B1.20B-2.36B-17.56B-9.83B8.98B-8.44B-6.29B-296.49M-12.90B
Investing Cash Flow-8.62B1.78B-6.49B-25.16B7.00B-10.00B1.78B7.05B-3.99B1.30B-
Financing Cash Flow2.95B23.30B118.44M27.99B9.51B15.76B-11.89B7.51B-753.78M-1.25B-
Capital Expenditure1.33B1.16B173.01M1.03B346.71M207.40M3.95B109.46M2.05B7.61M66.29B
Free Cash Flow-----13.58B-10.04B5.03B-8.59B-8.37B-304.46M-79.19B
FCF to OCF----77.30%102.13%55.99%101.82%133.13%102.69%613.76%

Earnings

Report DateMar 31, 2009Mar 31, 2010Jun 30, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 16, 2016Nov 14, 2016Feb 15, 2017May 12, 2017Aug 15, 2017Nov 14, 2017Feb 13, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 12, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 25, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------
EPS Actual-2764.47-2812.08-682.44-3050.00-5008.24-112.263553.77744.24658.04800.96-94.0091.03554.06-2005.99-18050.00-5998.57-1491.42-744.44-53.07-190.18-147.76-241.82-1124.38-113.1510.00-99.27-34.17-103.5165.6812.69-41.40-16.23-26.8762.12-173.18-8.58-18.03-16.43-232.14-489.80-450.50-1164.23-1459.60-609.28875.25-465.77-532.67-205.83-213.33106.331909.35-332.534.52-1498.2195.25170.59-126.48396.62-90.62-83.99-115.08-219.07-190.59-369.07
Surprise----------------------------------------------------------------
Timing------------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-------------------------

Key Statistics & Ratios

Market Cap52.63B
Enterprise Value200.80B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.70
Price / Book2.18
Revenue (TTM)-8.10B
Gross Profit (TTM)47.46M
EBITDA-2.96B
Profit Margin0.00%
Operating Margin45.06%
Return on Equity541.01%
Return on Assets-6.50%
Shares Outstanding29.51M
Shares Float13.12M
Beta1.18
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 7, 20261:5
  • May 26, 20141:5
  • Apr 29, 20111:2
  • Mar 30, 20061791:1610
  • Mar 23, 2005147:127